Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 782.64M P/E - EPS this Y -10.30% Ern Qtrly Grth -
Income -221.05M Forward P/E -4.96 EPS next Y 36.40% 50D Avg Chg -35.00%
Sales 6.52M PEG -0.07 EPS past 5Y - 200D Avg Chg -49.00%
Dividend N/A Price/Book 1.73 EPS next 5Y 45.80% 52W High Chg -80.00%
Recommedations 2.60 Quick Ratio 7.83 Shares Outstanding 210.39M 52W Low Chg 7.00%
Insider Own 1.65% ROA -28.90% Shares Float 206.99M Beta 0.49
Inst Own 37.98% ROE -56.86% Shares Shorted/Prior 44.74M/43.79M Price 3.72
Gross Margin - Profit Margin - Avg. Volume 4,703,806 Target Price 13.38
Oper. Margin -3,453.67% Earnings Date Feb 28 Volume 4,121,953 Change -5.58%
Inovio Pharmaceuticals, Inc. News
01/25/22 Here's Why Inovio (INO) Looks Ripe for Bottom Fishing
01/11/22 Down 21.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO)
01/11/22 Better Vaccine Stock: Ocugen vs. Inovio Pharmaceuticals
12/30/21 Is 15% Potential Upside Good Enough to Risk Buying Inovio Stock? Analyst Weighs In
12/21/21 Is Inovio Stock A Buy After The FDA Removed Its Hold On Covid Vaccine Testing?
12/19/21 Inovio Pharmaceuticals (NASDAQ:INO) Is Using Debt Safely
12/15/21 Inovio: Making Progress in the Cervical HSIL Program
12/15/21 3 Ultra-Popular Stocks Expected to Increase Sales 981% to 5,569% in 2022
12/14/21 INOVIO Highlights Key Updates on Phase 3 Program for VGX-3100, its DNA-based Immunotherapy for the Treatment of Cervical HSIL Caused by HPV-16 and/or HPV-18
12/03/21 Here's Why These 3 COVID-19 Vaccine Stocks Got Crushed This Week
12/03/21 2 Stocks That Are Down 60% (or More) From Their 52-Week Highs
12/02/21 Is Inovio Stock Set to Rebound?
11/30/21 INOVIO Announces Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 Variants
11/26/21 UPDATE 1-Novavax developing vaccine that targets new COVID-19 variant
11/26/21 Vaccine Stocks Benefit From Covid-19 Variant Concerns
11/21/21 Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen
11/21/21 3 Vaccine Latecomers That Could Double Your Money
11/17/21 Does This News Make Inovio Pharmaceuticals Stock a Buy?
11/16/21 INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon optimized plasmids that have ability to help break the immune system's tolerance of cancerous or infected cells and facilitate cross-strain protection against unmatched and matched pathogen variants. The company is involved in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, including head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company also has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800, which is currently in Phase I clinical testing for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

INO Chatroom

User Image ChartMill Posted - 48 minutes from now

$INO was analyzed by 13 analysts. The buy consensus is at 71%. So analysts seem to be mildly confident about $INO. https://www.chartmill.com/stock/analyzer/stock/INO?view=analyst-ratings&utm_source=stocktwits&utm_medium=ANALYST&utm_content=INO&utm_campaign=social_tracking

User Image marcin2017 Posted - 17 minutes from now

SARS-CoV-2 DNA Vaccine $INO INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial | The Journal of Infectious Diseases | Oxford Academic https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiac016/6515374

User Image Moneymiketx Posted - 11 minutes from now

$INO so this counts for inovio bringing a product to market. Lifetide SW5 is on the market now. It is an inovio product licensed thru Plumbline using inovio EP devices in Australia and New Zealand thru a partnership with Apiam. Not huge revenue but it is a 20 year agreement with a million doses planned. Also working on bringing others to market. https://product.statnano.com/product/8437/lifetide%C2%AE-sw-5 https://www.thepigsite.com/news/2019/05/pharmaceutical-companies-collaborate-to-develop-a-new-asf-vaccine

User Image wk91766 Posted - 4 minutes from now

$INO I am speechless SP is this low. I mean anyone from BP can buy inovio less than 800 Million market cap. CEO Kim should be fired. He has no clue how to run public trading company. Doesn't he realize higher the SP, the more you can raise capital to fund pipeline? The lower the price, it's hard to borrow money from lender or kill off long term investors dillouted shares. Where is BofD suppose to serve on behalf of shareholders? Public trading company have to provide annual shareholder meeting, but inovio have never offered or conducted annual shareholders meeting. It's so strange. I ask the community to tweeter feed fire CEO Kim hashtag. He is awful CEO, he wasted 2 years with ino-4800 by going by itself without partnering with BP from start of pandemic. Holding for better days.

User Image Drunkmasterz Posted - 7 minutes ago

$INO Sweden https://www.yahoo.com/news/sweden-decides-against-recommending-covid-142233166.html

User Image Marsan12 Posted - 57 minutes ago

$INO Oppenheimer Inovio at 4:20 https://youtu.be/R2d9uC0cfy8

User Image m633 Posted - 1 hour ago

$INO pls I wanna see one Green Day. WHO Advaccine Whoever it might be, pls ORDER INO4800!!!

User Image brotherm1 Posted - 2 hours ago

$INO ??? https://alexberenson.substack.com/p/vaccine-failure-in-two-charts-and/comments

User Image Iluvufor30s Posted - 2 hours ago

$INO Like many of you I am fed up. So, I have made a decision. I just got back from Walgreens, purchased about 10 adult diapers. Loaded my car up with 100 extra gallons of gas in containers in the trunk. At 2am tonight I am leaving for San Diego to go to INO HQ. My Waze calculations have me arriving Saturday at 11am. So at that time, I will go to the front desk and demand the following: 1) Demand Joseph Kim release a PR. 2) Demand INO-4802 in both arms. 3) Demand the Cellectra 3PSP used be signed by Dr. Kim AND Dr. Kate. I will then and only then leave the premise and start my journey home, using the same diaper I started with.

User Image jfvrt123 Posted - 2 hours ago

$INO here's your sign. I mean wtf? https://www.reuters.com/legal/government/pfizer-pushes-intervene-lawsuit-seeking-covid-vaccine-information-fda-2022-01-26/

User Image TangoRas Posted - 2 hours ago

$INO Kimchi cracking jokes in 2016 Still no Vac. Habitual liar WATCHLIVE logo MARKETS CNBC TV WATCHLIST MENU BIOTECH AND PHARMA We can rapidly move Zika and other vaccine studies forward: Inovio CEO PUBLISHED TUE, JUN 21 20163:57 PM EDTUPDATED TUE, JUN 21 20163:59 PM EDT

User Image chriscp Posted - 3 hours ago

$INO I believe many of you Longs have similar frustrating feelings like me with the management team, particularly the CEO, Dr Joseph Kim. My simple KPI for the CEO is just timely deliverables. There are too many claims by Kim which he has missed or didn't happen. IMO only three factors of its vaccines pipeline will cause a solid bounce in the SP 🚀 - Publication of high efficacy peer review data with EUA issuance. - Pre-orders & orders. - Buyout offer. C'mon Kim, no more radio silent! Speak up loud!

User Image Plasmasurfer Posted - 3 hours ago

$INO Inovio mentioned https://youtu.be/R2d9uC0cfy8

User Image Uncle1Sam Posted - 3 hours ago

$INO 1/27/22 “I cannot speak for them but I understand it is proceeding well. I am sure Advaccine will announce something when ready.” Q: Did Advaccine Finished recruiting for 2 trials: Sinovac’s Coronavac + 4800 heterologous and homologous? 11/8/21 China approves first mixed-vaccine trial as Delta spreads Study execute time: From 2021-11-30 To 2022-07-31 http://www.chictr.org.cn/hvshowproject.aspx?id=96875 https://www.france24.com/en/live-news/20210811-china-approves-first-mixed-vaccine-trial-as-delta-spreads Preclinical work has found that "two different vaccine applications... produce an even stronger and more balanced immune response", Advaccine chairman Wang Bin said in the statement. Beijing is yet to approve any foreign vaccines for domestic use.

User Image tradersgraphics Posted - 4 hours ago

$INO INO 2022-01-27 Daily Forecast Video: https://www.youtube.com/watch?v=53OGUUPCeF8

User Image joeddie23 Posted - 4 hours ago

$INO IMO MMS knew the market conditions and they also knew that regardless of news your stock would go down. Now the game has almost been played. Let’s see who come roaring back. Could it be us. YES

User Image Johnviking Posted - 4 hours ago

$INO Hopefully they will atleast release the earnings call date soon to get a temporary increase in stock price! Don’t know how Kim and the management can maintain their utter silence knowing the investors are loosing money.

User Image lolord Posted - 4 hours ago

$INO anyone gotta a spare 10k so I can average down

User Image lolord Posted - 4 hours ago

$INO haggard

User Image Johnviking Posted - 4 hours ago

$INO Are Drs Kim and Kate still at Inovio? Haven’t heard from them in a while. Maybe they are hiding just in case one of the unfortunate investor may find them and ask questions!

User Image bulldogsm Posted - 4 hours ago

$INO JK needs to invest in this awesome Vax co called Inovio and announce a 50mm share buyback, it makes more sense than sitting on a pile of cash that's only losing value with inflation going up, it's not like he has a use for the cash

User Image sixpointnine Posted - 5 hours ago

$INO “Remember…patience is waning.”

User Image HappyNewYear_77 Posted - 5 hours ago

$INO I think this is why Dr.Kim hates trees so much

User Image HappyNewYear_77 Posted - 5 hours ago

$INO how you gonna get beat by tree bark?

User Image HappyNewYear_77 Posted - 5 hours ago

$INO Novavax took some moths and tree bark, mixed them together, called it a vaccine, and the FDA gave them money for it and Novavax made lots of money....I remember...it all happened while Dr.Kim was shocking people in his "vaccine clinical trials" in his "laboratory"

User Image HappyNewYear_77 Posted - 5 hours ago

$INO I can believe it....Novavax beat Inovio with moths and tree bark

User Image zerosumgame1 Posted - 5 hours ago

$INO This is such an insult to Kim and INO. This is proof that all the millions he sucked out of investors was for himself and all the other executives at INO. Two professors at a college in Texas and 20 of their helpers were granted approval for their Covid vaccine last month in India. Two guys beat Kim, his hundreds of employees, and the $600 million he has pulled in by diluting shareholders. https://thehill.com/policy/healthcare/public-global-health/587533-india-approves-low-cost-vaccine-developed-in-texas?amp

User Image bigtonutz Posted - 5 hours ago

$INO

User Image HappyNewYear_77 Posted - 5 hours ago

$INO Dr.Kim is a freaking mad scientist, who is very evil... No one knows this but me ...the part of the vaccine where he shocks you to prime you up, that doesn't even have to happen for you to take his vaccine, you don't have to be primed to take his vaccine, he only shocks you cause it makes him happy...that's who you as Inovio investors are dealing with, A mad scientist who won't stop untill he has the whole world under his control with his sick twisted shock therapies and DNA splicing vaccine !!!....

User Image m633 Posted - 5 hours ago

$INO WHO is silent. INO is silent. Fauci never mentioned INO. FDA has stopped INO. I am trying to think of a slightest ray of hope.

Analyst Ratings
B of A Securities Neutral Jan 21, 22
RBC Capital Sector Perform Nov 1, 21
B of A Securities Underperform Sep 10, 21
Jefferies Hold Jun 24, 21
B of A Securities Neutral Mar 23, 21
Oppenheimer Outperform Feb 12, 21
Roth Capital Sell Nov 17, 20
Roth Capital Neutral Nov 10, 20
Cantor Fitzgerald Neutral Sep 28, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Weiner David B. Director Director Apr 21 Option 2.4 22,500 54,000 877,719 04/21/21
BENITO SIMON X Director Director Apr 16 Option 3.56 2,000 7,120 53,650 04/16/21
Weiner David B. Director Director Mar 09 Sell 9.39 7,000 65,730 843,552 03/09/21
Kim Jong Joseph Chief Executive Offi.. Chief Executive Officer Feb 03 Option 4.56 62,500 285,000 1,140,813 02/03/21
Kim Jong Joseph Chief Executive Offi.. Chief Executive Officer Feb 03 Sell 14.62 162,500 2,375,750 1,078,313 02/03/21
Shea Jacqueline Elizabeth Chief Operating Offi.. Chief Operating Officer Feb 03 Option 3.62 22,376 81,001 66,871 02/03/21
Shea Jacqueline Elizabeth Chief Operating Offi.. Chief Operating Officer Feb 03 Sell 15.03 28,336 425,890 38,535 02/03/21
KIES PETER CFO CFO Jan 15 Option 4.56 30,000 136,800 149,290 01/15/21
KIES PETER CFO CFO Jan 15 Sell 10.02 30,000 300,600 119,290 01/15/21
KIES PETER CFO CFO Dec 17 Option 2.28 20,000 45,600 139,290 12/17/20
KIES PETER CFO CFO Dec 17 Sell 10.69 20,000 213,800 119,290 12/17/20
Weiner David B. Director Director Dec 17 Option 4.56 17,500 79,800 844,719 12/17/20
Weiner David B. Director Director Dec 17 Sell 10.71 17,500 187,425 827,219 12/17/20